Cardiac Markers Tests Medical Devices Pipeline Assessment, 2015
Summary
GlobalDatas Medical Devices sector report, “Cardiac Markers Tests Medical Devices Pipeline Assessment, 2015 provides an overview of Cardiac Markers Tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Cardiac Markers Tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Cardiac Markers Tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to buy
The report enables you to
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Cardiac Markers Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the products current stage of development, territory and estimated launch date
Table Of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 21
2 Introduction 22
2.1 Cardiac Markers Tests Overview 22
3 Products under Development 23
3.1 Cardiac Markers Tests - Pipeline Products by Stage of Development 23
3.2 Cardiac Markers Tests - Pipeline Products by Segment 24
3.3 Cardiac Markers Tests - Pipeline Products by Territory 25
3.4 Cardiac Markers Tests - Pipeline Products by Regulatory Path 26
3.5 Cardiac Markers Tests - Pipeline Products by Estimated Approval Date 27
3.6 Cardiac Markers Tests - Ongoing Clinical Trials 28
4 Cardiac Markers Tests - Pipeline Products under Development by Companies 29
4.1 Cardiac Markers Tests Companies - Pipeline Products by Stage of Development 29
4.2 Cardiac Markers Tests - Pipeline Products by Stage of Development 35
5 Cardiac Markers Tests Companies and Product Overview 45
5.1 3PrimeDx, Inc. Company Overview 45
5.2 Abbott Diagnostics Company Overview 46
5.3 ACS Biomarker Company Overview 62
5.4 Adaltis S.r.l. Company Overview 63
5.5 AgPlus Diagnostics LTD Company Overview 64
5.6 Alere Inc. Company Overview 65
5.7 Alfa Scientific Designs, Inc. Company Overview 68
5.8 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 69
5.9 Alfa Wassermann, Inc. Company Overview 72
5.10 Amdix B.V. Company Overview 75
5.11 Analyticon Biotechnologies AG Company Overview 76
5.12 Applied Proteomics, Inc. Company Overview 78
5.13 Arrayit Diagnostics, Inc. Company Overview 79
5.14 Astute Medical, Inc. Company Overview 80
5.15 Aterovax SA Company Overview 81
5.16 Axela Inc. Company Overview 85
5.17 AXO Science S.A.S. Company Overview 86
5.18 Beckman Coulter, Inc. Company Overview 90
5.19 BG Medicine, Inc. Company Overview 94
5.20 Biocartis SA Company Overview 97
5.21 Biomarker Design Forschungs GmbH Company Overview 101
5.22 bioMerieux S.A. Company Overview 102
5.23 BiOracle Limited Company Overview 105
5.24 Bio-Rad Laboratories, Inc. Company Overview 106
5.25 Biouniversa s.r.l. Company Overview 108
5.26 CardioGenics Inc. Company Overview 109
5.27 Cavadis B.V. Company Overview 110
5.28 Cellgenex Diagnostics Company Overview 116
5.29 Centice Corporation Company Overview 117
5.30 Childrens Hospital Boston Company Overview 119
5.31 China Medical Technologies, Inc. Company Overview 121
5.32 China Sky One Medical, Inc. Company Overview 129
5.33 Cleveland HeartLab, Inc. Company Overview 130
5.34 Co-Diagnostics HBDC, Inc. Company Overview 131
5.35 CompanDX Ltd. Company Overview 132
5.36 Corgenix Medical Corporation Company Overview 133
5.37 Corgenix, Inc. Company Overview 138
5.38 Coris BioConcept Company Overview 139
5.39 Courtagen Life Sciences, Inc. Company Overview 140
5.40 CPD, LLC Company Overview 141
5.41 Critical Diagnostics Company Overview 142
5.42 DestiNA Genomics Ltd Company Overview 143
5.43 diaDexus, Inc. (Inactive) Company Overview 144
5.44 Diagnoptics Technologies B.V. Company Overview 148
5.45 DiaPat GmbH Company Overview 150
5.46 ELITech Group Company Overview 151
5.47 EnCare Biotech B.V. Company Overview 153
5.48 Firalis SAS Company Overview 154
5.49 Fundacio Clinic per a la Recerca Biomedica Company Overview 160
5.50 Gamma Therapeutics, Inc. Company Overview 161
5.51 GeneNews Limited Company Overview 163
5.52 Genesis Detection Systems, Inc. Company Overview 167
5.53 Global Genomics Group, LLC Company Overview 169
5.54 Grifols, S.A. Company Overview 170
5.55 Hannover Medical School Company Overview 172
5.56 Hospices Civils de Lyon Company Overview 174
5.57 IMMUNARRAY LTD. Company Overview 175
5.58 Immunodiagnostic Systems Holdings plc Company Overview 176
5.59 Infigo Diagnostics Ltd Company Overview 179
5.60 infYnity biomarkers S.A.S. Company Overview 180
5.61 Insilicos LLC Company Overview 181
5.62 Institut National de la Sante et de la Recherche Medicale Company Overview 182
5.63 iXensor Co. Ltd. Company Overview 186
5.64 Kamiya Biomedical Company Company Overview 187
5.65 KineMed, Inc. Company Overview 188
5.66 Kings College London Company Overview 189
5.67 LipoScience, Inc. Company Overview 193
5.68 Marshall University Company Overview 194
5.69 Mayo Clinic. Company Overview 195
5.70 Medical University of South Carolina Company Overview 196
5.71 Mediomics, LLC Company Overview 200
5.72 MedMira Inc. Company Overview 201
5.73 MetaboGen AB Company Overview 203
5.74 Metanomics Health GmbH Company Overview 204
5.75 Mindray Medical International Limited Company Overview 206
5.76 MMBiosensing, LLC Company Overview 210
5.77 Nanosphere, Inc. Company Overview 211
5.78 NorthShore University Health System Company Overview 214
5.79 Nuclea Biotechnologies Inc. Company Overview 215
5.80 One Drop Diagnostics Company Overview 216
5.81 Oran Diagnostics, LLC Company Overview 217
5.82 Oregon Health & Science University Company Overview 218
5.83 Ortho-Clinical Diagnostics Inc. Company Overview 220
5.84 Pacific Nanoscience, Inc. Company Overview 224
5.85 Parque Científico de Madrid Company Overview 225
5.86 Prevencio, LLC Company Overview 226
5.87 Prognosys LLC Company Overview 227
5.88 Pronota NV Company Overview 228
5.89 Proof Centre of Excellence Company Overview 231
5.90 Proplex Technologies, Llc Company Overview 234
5.91 Proteome Sciences Plc Company Overview 235
5.92 QLIDA Diagnostics Company Overview 237
5.93 Quest Diagnostics Incorporated Company Overview 238
5.94 Radiometer Medical ApS Company Overview 240
5.95 Randox Laboratories Limited Company Overview 247
5.96 Rheonix, Inc. Company Overview 252
5.97 Rice University Company Overview 253
5.98 RMIT University Company Overview 255
5.99 Rna Diagnostics Inc. Company Overview 256
5.100 Roche Diagnostics International Ltd. Company Overview 257
5.101 ROS Technologies, Inc Company Overview 266
5.102 Rosetta Genomics, Ltd. Company Overview 267
5.103 SATT South East Company Overview 269
5.104 Siemens Healthcare Diagnostics Inc. Company Overview 270
5.105 Singulex, Inc. Company Overview 291
5.106 Skyline Diagnostics BV Company Overview 296
5.107 SomaLogic, Inc. Company Overview 297
5.108 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 300
5.109 Tcoag Us Inc Company Overview 301
5.110 Tethys Bioscience, Inc. Company Overview 302
5.111 The Johns Hopkins University Company Overview 303
5.112 The Pennsylvania State University Company Overview 308
5.113 The University of Adelaide Company Overview 310
5.114 The University of Tokyo Company Overview 311
5.115 Thermo Fisher Scientific Inc. Company Overview 313
5.116 ThreeFold Sensors (Inactive) Company Overview 316
5.117 TissueNetix, Inc. Company Overview 318
5.118 Toshiba Medical Systems Corporation Company Overview 319
5.119 Tosoh Bioscience, Inc. Company Overview 320
5.120 True Diagnostics, Inc. Company Overview 327
5.121 Universite de Montreal Company Overview 329
5.122 University College Dublin Company Overview 331
5.123 University of California, San Diego Company Overview 333
5.124 University of California, San Francisco Company Overview 334
5.125 University of Colorado Company Overview 336
5.126 University of Illinois Company Overview 339
5.127 University of Nebraska Company Overview 340
5.128 University of Oslo Company Overview 341
5.129 University of Otago Company Overview 343
5.130 University of Texas Medical Branch at Galveston Company Overview 344
5.131 Vaiomer, SAS Company Overview 346
5.132 Vanderbilt University Company Overview 348
5.133 VEGA Ltd Company Overview 349
5.134 Vermillion, Inc. Company Overview 350
5.135 Vital Diagnostics, Inc. Company Overview 352
5.136 Warnex Inc. (Inactive) Company Overview 354
5.137 Washington University School of Medicine Company Overview 355
6 Cardiac Markers Tests- Recent Developments 357
7 Appendix 415
7.1 Methodology 415
7.2 About GlobalData 417
7.3 Contact Us 418
7.4 Disclaimer 418
List Of Tables
1.1 List of Tables
Table 1: Cardiac Markers Tests - Pipeline Products by Stage of Development 26
Table 2: Cardiac Markers Tests - Pipeline Products by Segment 27
Table 3: Cardiac Markers Tests - Pipeline Products by Territory 28
Table 4: Cardiac Markers Tests - Pipeline Products by Regulatory Path 29
Table 5: Cardiac Markers Tests - Pipeline Products by Estimated Approval Date 30
Table 6: Cardiac Markers Tests - Ongoing Clinical Trials 31
Table 7: Cardiac Markers Tests Companies - Pipeline Products by Stage of Development 32
Table 8: Cardiac Markers Tests - Pipeline Products by Stage of Development 38
Table 9: 3PrimeDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
Table 10: PulsePredic Test - Product Status 48
Table 11: PulsePredic Test - Product Description 48
Table 12: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 49
Table 13: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Status 50
Table 14: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Description 50
Table 15: ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Status 51
Table 16: ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Description 51
Table 17: ARCHITECT c4000 Integrated System - Galectin-3 Assay - Product Status 52
Table 18: ARCHITECT c4000 Integrated System - Galectin-3 Assay - Product Description 52
Table 19: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Status 53
Table 20: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Description 53
Table 21: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Status 54
Table 22: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Description 54
Table 23: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Status 55
Table 24: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Description 55
Table 25: ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Status 56
Table 26: ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Description 56
Table 27: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Status 57
Table 28: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Description 57
Table 29: ARCHITECT ci4100 Integrated System - High Sensitive Troponin-I Assay - Product Status 58
Table 30: ARCHITECT ci4100 Integrated System - High Sensitive Troponin-I Assay - Product Description 58
Table 31: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Status 59
Table 32: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Description 59
Table 33: ARCHITECT ci8200 Integrated System - High Sensitive Troponin-I Assay - Product Status 60
Table 34: ARCHITECT ci8200 Integrated System - High Sensitive Troponin-I Assay - Product Description 60
Table 35: ARCHITECT ci8200 Integrated System - NT Pro BNP Assay - Product Status 61
Table 36: ARCHITECT ci8200 Integrated System - NT Pro BNP Assay - Product Description 61
Table 37: ARCHITECT i1000SR - NT Pro BNP Assay - Product Status 62
Table 38: ARCHITECT i1000SR - NT Pro BNP Assay - Product Description 62
Table 39: ARCHITECT i2000SR - NT Pro BNP Assay - Product Status 63
Table 40: ARCHITECT i2000SR - NT Pro BNP Assay - Product Description 63
Table 41: ARCHITECT i4000SR Integrated System - High Sensitive Troponin-I Assay - Product Status 64
Table 42: ARCHITECT i4000SR Integrated System - High Sensitive Troponin-I Assay - Product Description 64
Table 43: ACS Biomarker Pipeline Products & Ongoing Clinical Trials Overview 65
Table 44: Multi-marker Heart Failure Assay - Product Status 65
Table 45: Multi-marker Heart Failure Assay - Product Description 65
Table 46: Adaltis S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 66
Table 47: CLIAgen Cardiac Marker Assay - Product Status 66
Table 48: CLIAgen Cardiac Marker Assay - Product Description 66
Table 49: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 67
Table 50: AgPlus Diagnostic System - Troponin I Assay - Product Status 67
Table 51: AgPlus Diagnostic System - Troponin I Assay - Product Description 67
Table 52: Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
Table 53: Afinion hsCRP Assay - Product Status 69
Table 54: Afinion hsCRP Assay - Product Description 69
Table 55: Galectin-3 Test - Triage Meter Pro - Product Status 70
Table 56: Galectin-3 Test - Triage Meter Pro - Product Description 70
Table 57: Alfa Scientific Designs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
Table 58: Instant-View Cardiac 3-in-1 Whole Blood/Serum Test - Product Status 71
Table 59: Instant-View Cardiac 3-in-1 Whole Blood/Serum Test - Product Description 71
Table 60: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 72
Table 61: ACE Axcel System - Apo A1 Assay - Product Status 72
Table 62: ACE Axcel System - Apo A1 Assay - Product Description 72
Table 63: ACE Axcel System - Apo B Assay - Product Status 73
Table 64: ACE Axcel System - Apo B Assay - Product Description 73
Table 65: ACE Axcel System - HsCRP Assay - Product Status 74
Table 66: ACE Axcel System - HsCRP Assay - Product Description 74
Table 67: Alfa Wassermann, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
Table 68: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Status 76
Table 69: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Description 76
Table 70: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Status 77
Table 71: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Description 77
Table 72: Amdix B.V. Pipeline Products & Ongoing Clinical Trials Overview 78
Table 73: Chitotriosidase Biomarker - Atherosclerosis - Product Status 78
Table 74: Chitotriosidase Biomarker - Atherosclerosis - Product Description 78
Table 75: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 79
Table 76: Turbitex APO A1 - Product Status 79
Table 77: Turbitex APO A1 - Product Description 79
Table 78: Turbitex APO B - Product Status 80
Table 79: Turbitex APO B - Product Description 80
Table 80: Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
Table 81: API Diagnostic Test - Cardiovascular Disease - Product Status 81
Table 82: API Diagnostic Test - Cardiovascular Disease - Product Description 81
Table 83: Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
Table 84: Companion Diagnostic Test - Plavix - Product Status 82
Table 85: Companion Diagnostic Test - Plavix - Product Description 82
Table 86: Astute Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
Table 87: Diagnostic Test - Acute Coronary Syndrome - Product Status 83
Table 88: Diagnostic Test - Acute Coronary Syndrome - Product Description 83
Table 89: Aterovax SA Pipeline Products & Ongoing Clinical Trials Overview 84
Table 90: AteroDx Combo - Product Status 85
Table 91: AteroDx Combo - Product Description 85
Table 92: AteroDx ISO - Product Status 86
Table 93: AteroDx ISO - Product Description 86
Table 94: sPLA2 Atherosclerosis Test - Asymptomatic Patients - Product Status 87
Table 95: sPLA2 Atherosclerosis Test - Asymptomatic Patients - Product Description 87
Table 96: Axela Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
Table 97: Cardiac Troponin Biomarker Kit - Product Status 88
Table 98: Cardiac Troponin Biomarker Kit - Product Description 88
Table 99: AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 89
Table 100: Multiplexed Detection - BNP - Product Status 89
Table 101: Multiplexed Detection - BNP - Product Description 89
Table 102: Multiplexed Detection - CRP - Product Status 90
Table 103: Multiplexed Detection - CRP - Product Description 90
Table 104: Multiplexed Detection - Myoglobin - Product Status 91
Table 105: Multiplexed Detection - Myoglobin - Product Description 91
Table 106: Multiplexed Detection - Troponin - Product Status 92
Table 107: Multiplexed Detection - Troponin - Product Description 92
Table 108: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
Table 109: SYNCHRON LXi 725 Anti-Cardiolipin Assay - Product Status 94
Table 110: SYNCHRON LXi 725 Anti-Cardiolipin Assay - Product Description 94
Table 111: SYNCHRON LXi 725 Ischemia Modified Albumin Assay - Product Status 95
Table 112: SYNCHRON LXi 725 Ischemia Modified Albumin Assay - Product Description 95
Table 113: UniCel DxC 600i Synchron Access ß2-Glycoprotein 1 Ab Assay - Product Status 96
Table 114: UniCel DxC 600i Synchron Access ß2-Glycoprotein 1 Ab Assay - Product Description 96
Table 115: BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
Table 116: BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Status 98
Table 117: BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Description 98
Table 118: BGM Galectin-3 Test - Onset Heart Failure - Product Status 99
Table 119: BGM Galectin-3 Test - Onset Heart Failure - Product Description 99
Table 120: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 100
Table 121: Biomarker Assay - Acute Cardiac Stress - Product Status 101
Table 122: Biomarker Assay - Acute Cardiac Stress - Product Description 101
Table 123: Biomarker Assay - Congestive Heart Failure - Product Status 102
Table 124: Biomarker Assay - Congestive Heart Failure - Product Description 102
Table 125: Evalution - Cardiac Assay - Product Status 103
Table 126: Evalution - Cardiac Assay - Product Description 103
Table 127: Biomarker Design Forschungs GmbH Pipeline Products & Ongoing Clinical Trials Overview 104
List Of Figures
1.2 List of Figures
Figure 1: Cardiac Markers Tests - Pipeline Products by Stage of Development 26
Figure 2: Cardiac Markers Tests - Pipeline Products by Segment 27
Figure 3: Cardiac Markers Tests - Pipeline Products by Territory 28
Figure 4: Cardiac Markers Tests - Pipeline Products by Regulatory Path 29
Figure 5: Cardiac Markers Tests - Pipeline Products by Estimated Approval Date 30
Figure 6: Cardiac Markers Tests - Ongoing Clinical Trials 31
